已收盤 11-20 16:00:00 美东时间
-0.430
-8.87%
11月17日,Electrocore Llc(ECOR)收跌7.81%,报4.84美元,成交额82.79万美元,市值4465.39万美元。 行情数据 • 开盘价...
11-17 08:26
electroCore shares are trading lower. The company announced results from a randomized, open-label, controlled study evaluating non-invasive autonomic neuromodulation in adults with Long COVID.
11-13 01:38
11月10日,Electrocore Llc(ECOR)收跌0.97%,报7.18美元,成交额315.47万美元,市值6624.27万美元。 行情数据 • 开盘...
11-10 08:17
electroCore, Inc. announced that its management will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 11, 2026, in New York City. Joshua Lev, Co-CEO, President, and CFO, will present at the conference and host investor meetings. Interested investors should contact their Canaccord Genuity sales representative. electroCore specializes in non-invasive bioelectronic technologies, offering produ...
11-05 13:00
electroCore (NASDAQ:ECOR) Sees FY 2027 revenue guidance of 30% to 40% YoY
11-05 06:04
electroCore (NASDAQ:ECOR) raises FY2026 sales outlook from $41.600 million to $41.642 million vs $41.915 million estimate.
11-05 05:38
11月3日,Electrocore Llc(ECOR)收跌4.79%,报7.16美元,成交额70.84万美元,市值6455.37万美元。 行情数据 • 开盘价...
11-03 08:14
electroCore, Inc. will report its Q3 2026 financial results on November 4, 2026, after market close. Management will host a conference call and webcast at 4:30 PM EST that day to discuss the results. Participants can join via telephone (877-407-8835 / +1 201-689-8779) or webcast using the provided link. A replay will be available on the company’s investor website. The company specializes in bioelectronic technologies for health and wellness, with...
10-29 12:00
electroCore, Inc. (NASDAQ:ECOR), ("electroCore" or the "Company"), a bioelectronic technology company, today announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) seeking 510(k) clearance for its Quell® wearable neuromodulation platform ("Quel...
10-28 20:03
A controlled study involving 50 healthy adults conducted by the United States Air Force Research Laboratory (AFRL) using electroCore's tcVNS technology suggests that transcutaneous cervical vagus nerve stimulation can enhance complex visual skill learning. Results indicate accelerated learning, improved executive efficiency, and stronger behavioral coordination during a visual pattern-recognition task. The study also shows reduced long-term deman...
10-27 12:00